Invivo Therapeutics Holdings Corp  

(Public, OTCMKTS:NVIV)   Watch this stock  
Find more results for OTC:NVIV
-0.01 (-0.50%)
Delayed:   10:36AM EST
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 1.93 - 2.04
52 week 0.47 - 2.67
Open 1.98
Vol / Avg. 220,955.00/1.15M
Mkt cap 185.75M
P/E     -
Div/yield     -
EPS -0.18
Shares 93.81M
Beta 17.39
Inst. own 10%
Nov 5, 2014
Q3 2014 InVivo Therapeutics Holdings Corp Earnings Release

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -22.11% -233.76%
Return on average equity -35.30% -732.67%
Employees 45 -
CDP Score - -


1 Kendall Sq Fl 4
CAMBRIDGE, MA 02139-1562
United States - Map
+1-617-8635524 (Phone)

Website links


InVivo Therapeutics Holdings Corp., formerly Design Source, Inc. is a medical device company engaged in developing and commercializing technologies for the treatment of spinal cord injuries (SCI). The Company develops biopolymer scaffolding devices for the treatment of spinal cord injuries and also to develop its novel Neuro-Spinal Scaffold to treat acute SCI and Neuro-Scaffold Plus Stem Cells to treat chronic SCI. The Company�s Bioresorbable Polymer Scaffold Device is a bioresorbable material that will be inserted into the spinal cord at the center of the site of injury. Its Bioresorbable Hydrogels is for the controlled release of small molecules and proteins.

Officers and directors

Mark D. Perrin Chief Executive Officer, Director
Age: 57
Steven F. McAllister Chief Financial Officer
Age: 56
Tamara L. Joseph J.D. Senior Vice President, Chief Compliance Officer, General Counsel
Age: 51
Thomas R. Ulich M.D. Chief Scientific Officer
Age: 60
John A. McCarthy Jr. Non-Executive Independent Chairman of the Board
Age: 54
Daniel R. Marshak Ph.D. Director
Age: 56
Ann Merrifield Director
Kenneth A. Di Pietro Independent Director
Age: 55
Richard J. Roberts Ph.D. Independent Director
Age: 70